This inventor holds 5 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Clarity Pharmaceuticals Ltd. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations of Nicholas Alan Zia
Introduction
Nicholas Alan Zia is a prominent inventor based in Melbourne, Australia. He has made significant contributions to the field of radiopharmaceuticals and radioimaging agents. With a total of 5 patents to his name, Zia's work has advanced the capabilities of diagnostic imaging and therapeutic methods.
Latest Patents
Zia's latest patents focus on compounds that serve as radiopharmaceuticals and radioimaging agents. These compounds incorporate a radionuclide-chelating agent, making them valuable in both radiotherapy and diagnostic imaging. His inventions also encompass methods for diagnosis, prognosis, and therapy utilizing these innovative radiolabelled compounds.
Career Highlights
Nicholas Alan Zia is associated with Clarity Pharmaceuticals Ltd, where he continues to develop groundbreaking technologies in the medical field. His expertise in radiopharmaceuticals has positioned him as a key player in advancing medical imaging techniques.
Collaborations
Zia collaborates with notable professionals in his field, including Paul Stephen Donnelly. Their combined efforts contribute to the ongoing research and development of innovative medical solutions.
Conclusion
Nicholas Alan Zia's contributions to the field of radiopharmaceuticals and radioimaging agents highlight his role as a leading inventor. His work not only enhances diagnostic capabilities but also paves the way for future advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile